"[B40F5AD2D790]" . . . "Aim of the study was to evaluate plasma levels of markers of structural myocardial damage in patients with hypertrophic cardiomyopathy (HCM). 21 pts with HCM was enrolled into the study. Echo and catheterization were performed before enrolment into the study. We analyzed plasma troponin I (cTnI), troponin T (TnT), creatine kinase MB concentration (CK-MB), glycogenphosphorylase BB (GPBB), heart fatty acid binding protein (hFABP) and myoglobin (myo) levels. Compare to control group, plasma levels all evaluated parameters were significantly increased. Furthermore, we observed correlation between left ventricle mass and its index with plasma GPBB level. While plasma troponin I level reached the cut-off limit for detection of myocardial injury in 5 patients, plasma troponin T level reached detection limit only in 1 patient. Our study found increase of plasma markers of structural myocardial damage (cTnI, GPBB, CK-MB, hFABP and myoglobin)."@en . "5"^^ . "Interven\u010Dn\u00ED a akutn\u00ED kardiologie" . "Hladiny marker\u016F poruchy struktury myokardu u pacient\u016F s hypertrofickou kardiomyopati\u00ED." . "G44" . . . . . . "Len\u010Do, Juraj" . "RIV/60162694:G44__/09:00002220" . . . . . "Ulrychov\u00E1, M." . . "Pudil, R." . "Hladiny marker\u016F poruchy struktury myokardu u pacient\u016F s hypertrofickou kardiomyopati\u00ED."@cs . . "RIV/60162694:G44__/09:00002220!RIV10-MZ0-G44_____" . "9"^^ . "Levels of myocardial damage markers in patients with hypetrophic cardiomyopathy."@en . "Fu\u010D\u00EDkov\u00E1, Alena" . "Tich\u00FD, Milo\u0161" . . "\u00DA\u010Del studie: Vyhodnotit hladiny marker\u016F struktur\u00E1ln\u00EDho po\u0161kozen\u00ED myokardu u nemocn\u00FDch s hypertrofickou kardiomyopati\u00ED (HKMP). Do studie bylo za\u0159azeno 21 pacient\u016F s HKMP, u kter\u00FDch bylo p\u0159ed za\u0159azen\u00EDm do studie provedeno echokardiografick\u00E9 a katetriza\u010Dn\u00ED vy\u0161et\u0159en\u00ED. Byly analyzov\u00E1ny plazmatick\u00E9 hladiny srde\u010Dn\u00EDho troponinu I (cTnI), troponinu T (TnT), koncentrace MB izoenzymu kreatinkin\u00E1zy CK-MB), mastn\u00E9 kyseliny v\u00E1\u017E\u00EDc\u00EDho proteinu (hFABP), glykogenfosforyl\u00E1zy BB (GPBB) a myoglobinu (MYO). V porovn\u00E1n\u00ED s kontroln\u00ED skupinou byly plazmatick\u00E9 hladiny sledovan\u00FDch parametr\u016F struktur\u00E1ln\u00EDho posti\u017Een\u00ED myokardu signifikantn\u011B zv\u00FD\u0161eny."@cs . . "Stul\u00EDk, Ji\u0159\u00ED" . "Pali\u010Dka, V." . "CZ - \u010Cesk\u00E1 republika" . . "hypertrophic cardiomyopathy; glycogen phosphorylase BB; heart fatty acid binding protein; myoglobin; cardiac troponin"@en . "\u00DA\u010Del studie: Vyhodnotit hladiny marker\u016F struktur\u00E1ln\u00EDho po\u0161kozen\u00ED myokardu u nemocn\u00FDch s hypertrofickou kardiomyopati\u00ED (HKMP). Do studie bylo za\u0159azeno 21 pacient\u016F s HKMP, u kter\u00FDch bylo p\u0159ed za\u0159azen\u00EDm do studie provedeno echokardiografick\u00E9 a katetriza\u010Dn\u00ED vy\u0161et\u0159en\u00ED. Byly analyzov\u00E1ny plazmatick\u00E9 hladiny srde\u010Dn\u00EDho troponinu I (cTnI), troponinu T (TnT), koncentrace MB izoenzymu kreatinkin\u00E1zy CK-MB), mastn\u00E9 kyseliny v\u00E1\u017E\u00EDc\u00EDho proteinu (hFABP), glykogenfosforyl\u00E1zy BB (GPBB) a myoglobinu (MYO). V porovn\u00E1n\u00ED s kontroln\u00ED skupinou byly plazmatick\u00E9 hladiny sledovan\u00FDch parametr\u016F struktur\u00E1ln\u00EDho posti\u017Een\u00ED myokardu signifikantn\u011B zv\u00FD\u0161eny." . "8" . "Hor\u00E1\u010Dek, Jan" . "6" . "Hladiny marker\u016F poruchy struktury myokardu u pacient\u016F s hypertrofickou kardiomyopati\u00ED." . "1213-807X" . "4"^^ . "Hladiny marker\u016F poruchy struktury myokardu u pacient\u016F s hypertrofickou kardiomyopati\u00ED."@cs . . "Voj\u00E1\u010Dek, J." . . . . "P(NR9253)" . "Levels of myocardial damage markers in patients with hypetrophic cardiomyopathy."@en . "317361" .